The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.
Source: [MarketWatch](https://www.marketwatch.com/story/modernas-stock-doubles-on-promising-cancer-vaccine-results-896b1f2c?mod=mw_rss_topstories)
With smarter gym tracking, new health alerts, and offline Gemini, the Pixel Watch 5 fine-tunes a winning formula—for a price.
Trump nominated Overton to be the next commissioner of the Food and Drug Administration.
A record surge in Moderna Inc. ’s shares delivered a $5 billion blow to short sellers who had bet that the vaccine maker’s years-long slump would continue.
Developing story — details emerging. Check the source link for the latest updates.
2 points, 1 comments on Hacker News
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock’s biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co. ’s Keytruda helped cut the recurrence of melanoma in a large, late-stage tria...